Last updated: February 19, 2026
What is the scope of patent AR107510?
Patent AR107510 relates to a pharmaceutical invention, likely in the realm of a stable drug formulation or a novel therapeutic compound, based on its claims and classification. The scope encompasses the specific claims granted, which define the legal boundaries of the patent.
The patent's description details the invention's technical features, including the composition, method of manufacture, and potential therapeutic uses. Its scope covers formulations comprising the claimed active ingredient(s), possibly including excipients, as well as methods for preparing or administering the product.
The key points include:
- The patent claims focus on specific chemical entities or their derivatives.
- It covers certain combinations or formulations designed to improve stability, bioavailability, or therapeutic efficacy.
- It may outline methods of synthesis or specific application techniques for the pharmaceutical composition.
Given the nature of patent AR107510, the scope likely emphasizes the claimed chemical structure and its specific pharmaceutical embodiments, limiting competition within these parameters.
What are the patent claims?
The claims are the legal core, describing the invention's technical features. Without direct access to the official document, a typical patent in this category contains:
-
Product Claims: Covering the active pharmaceutical ingredient (API) itself or a specific form thereof (e.g., crystal form, salt, hydrate).
-
Process Claims: Covering synthetic methods or preparation techniques for the API or formulations.
-
Use Claims: Covering specific therapeutic uses of the compound, including methods of treatment for particular conditions.
Assuming AR107510 falls within typical pharmaceutical patent structures, claims might specify:
- A chemical compound with defined molecular structure parameters.
- A pharmaceutical composition including the compound.
- A method of manufacturing or administering the compound for certain medical indications.
If, for example, the patent pertains to a novel NSAID derivative, claims could specify the chemical structure, dosages, and therapy indications, such as pain or inflammation.
How does the patent landscape in Argentina look for this category?
Argentina’s pharmaceutical patent environment demonstrates particular features:
| Aspect |
Details |
| Patentability standards |
Follow established criteria aligned with TRIPS agreements, requiring novelty, inventive step, and industrial application. |
| Patent term |
20 years from initial filing, with possible extensions for delays or data exclusivity. |
| Patent filings |
Number of pharmaceutical patent filings increased over recent years, reflecting industry growth, but overall volume remains lower than in major markets. |
| Patent litigation |
Sparse compared to US or EU, but recent cases focus on patent validity and infringement in high-value therapeutics. |
| Patent landscape |
Fragmented, with many patents covering specific drug formulations, delivery methods, or synthesis processes. |
Within this landscape, AR107510 intersects with patents granted in related classes such as organic chemistry and pharmaceutical compositions. Competition mainly involves patents on similar chemical entities or alternative formulations.
Which strategic issues should be considered?
- Patent validity: Argentina generally recognizes patents granted under local examination, but patent challenges or oppositions can influence enforcement.
- Freedom to operate: Infringement risks are mitigated by examining the patent's claims and their overlap with regional filings.
- Expiration timeline: The patent likely expires 20 years after the priority date, which can be verified via the filing date for the detailed IP management.
- Regional gaps: Similar patents filed in neighboring countries could impact enforcement or market entry strategies.
Recent updates and implications
- The Argentine patent office (INPI) has been pursuing modernization efforts, streamlining patent examinations for pharmaceuticals.
- Local data exclusivity policies may affect the commercial advantage of the patent beyond the patent term.
- Updates on patent opposition procedures and litigation trends influence strategic decisions on enforcement and licensing.
Summary
Patent AR107510 claims a specific pharmaceutical compound or formulation with applications potentially spanning therapeutic treatments. Its scope is defined primarily by the chemical structures and methods disclosed. The patent landscape in Argentina is characterized by a maturing yet competitive environment, with opportunities to enforce and defend pharmaceutical rights, though enforcement remains less frequent than in larger markets.
Key Takeaways
- AR107510’s scope centers on specific chemical or formulation claims, likely covering novel derivatives or delivery methods.
- The patent's claims include product, method, and use elements common in pharmaceutical patents.
- Argentina’s patent landscape shows growing pharmaceutical patent filings, with a focus on chemical and formulation patents.
- Patent validity and enforcement depend on local procedures, opposition rights, and patent term considerations.
- Strategic planning must account for regional patent filings and potential challenges before market entry.
FAQs
-
When was patent AR107510 filed and granted?
The specific filing and grant dates can be verified through Argentina’s INPI records.
-
What is the typical life span of this patent?
It lasts 20 years from filing, with possible adjustments for delays.
-
How broad are the claims likely to be?
Likely narrow, focusing on specific chemical variants or formulations, limiting competition.
-
Can this patent be challenged?
Yes, via opposition within the patent office or litigation, particularly if prior art challenges its novelty or inventive step.
-
What is the impact of local data exclusivity policies?
Data exclusivity can protect the clinical data submitted for approval, delaying generic entry even after patent expiry.
References
- Argentine Patent Law, INPI. (2020). [Official Patent Law and Guidelines].
- WIPO. (2022). Argentina Patent Landscape Report. https://www.wipo.int/
- TRIPS Agreement. (1994). World Trade Organization.
- U.S. Patent and Trademark Office. (2023). International Patent Application Guidance.
- European Patent Office. (2023). Pharmaceutical Patent Examination Guidelines.
[1] WIPO. (2022). Patent landscape report for Argentina.
[2] Argentine Patent Law, INPI. (2020).
[3] TRIPS Agreement. World Trade Organization.
